114
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Determinants of medical prescriptions for COPD care: an analysis of the EPOCONSUL clinical audit

, , , , , & show all
Pages 2279-2288 | Published online: 27 Jul 2018

References

  • VogelmeierCFCrinerGJMartinezFJGlobal strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summaryAm J Respir Crit Care Med2017195555758228128970
  • MiravitllesMSoler-CatalunaJJCalleMSpanish guidelines for management of chronic obstructive pulmonary disease (GesEPOC) 2017. Pharmacological treatment of stable phaseArch Bronconeumol201753632433528477954
  • SundhJJansonCJohanssonGCharacterization of secondary care for COPD in SwedenEur Clin Respir J201741127007928326177
  • SimeoneJCLuthraRKailaSInitiation of triple therapy maintenance treatment among patients with COPD in the USInt J Chron Obstruct Pulmon Dis201712738328053518
  • MapelDLaliberteFRobertsMHA retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapyInt J Chron Obstruct Pulmon Dis2017121825183628684905
  • Gruffydd-JonesKBrusselleGJonesRChanges in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observationalNPJ Prim Care Respir Med2016261600228358398
  • ChalmersJDTebbothAGayleATernouthARamscarNDeterminants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practiceNPJ Prim Care Respir Med20172714328663549
  • DingBSmallMTreatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world surveyInt J Chron Obstruct Pulmon Dis2017121753176328670116
  • SouliotisKKaniCPapageorgiouMLionisDGourgoulianisKUsing big data to assess prescribing patterns in Greece: the case of chronic obstructive pulmonary diseasePLoS One2016115e015496027191724
  • Roman-RodriguezMvan BovenJFVargasFFactors associated with inhaled corticosteroids prescription in primary care patients with COPD: a cross-sectional study in the Balearic Islands (Spain)Eur J Gen Pract201622423223927597172
  • HaycockCSchandlAA new tool for quality: the internal auditNurs Adm Q201741432132728859000
  • RuparelMLopez-CamposJLCastro-AcostaAHartlSPozo-RodriguezFRobertsCMUnderstanding variation in length of hospital stay for COPD exacerbation: European COPD auditERJ Open Res201621pii00034-2015
  • SpruitMAPittaFGarveyCERS Rehabilitation and Chronic Care, and Physiotherapists Scientific Groups, American Association of Cardiovascular and Pulmonary Rehabilitation, ATS Pulmonary Rehabilitation Assembly and the ERS COPD Audit TeamDifferences in content and organisational aspects of pulmonary rehabilitation programmesEur Respir J20144351326133724337043
  • RobertsCMLopez-CamposJLPozo-RodriguezFHartlSEuropean COPD Audit TeamEuropean hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissionsThorax201368121169117123729193
  • Lopez-CamposJLAbad ArranzMCalero AcunaCClinical audits in outpatient clinics for chronic obstructive pulmonary disease: methodological considerations and workflowPLoS One20151011e014185626544556
  • Lopez-CamposJLAbad ArranzMCalero AcunaCDeterminants for changing the treatment of COPD: a regression analysis from a clinical auditInt J Chron Obstruct Pulmon Dis2016111171117827330285
  • Calle RubioMAlcazar NavarreteBSorianoJBClinical audit of COPD in outpatient respiratory clinics in Spain: the EPOCONSUL studyInt J Chron Obstruct Pulmon Dis20171241742628182155
  • DahlRJadayelDAlagappanVKChenHBanerjiDEfficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON studyInt J Chron Obstruct Pulmon Dis2013850150824159259
  • HagedornCKassnerFBanikNNtampakasPFielderKInfluence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPDRespir Med2013107454254923337300
  • VestboJPapiACorradiMSingle inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trialLancet2017389100821919192928385353
  • BremnerPRBirkRBrealeyNIsmailaASZhuCQLipsonDASingle-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority studyRespir Res20181911929370819
  • MiravitllesMSoler-CatalunaJJCalleMSpanish COPD guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish society of pulmonology and thoracic surgeryArch Bronconeumol201248724725722561012
  • SorianoJBLamprechtBRamirezASMortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient dataLancet Respir Med20153644345025995071
  • CalabroGEDe WaureCMoginiVClinical audit as a quality improvement tool in the emergency setting. A systematic review of the literatureIg Sanita Pubbl201672544347928068677
  • Lopez-CamposJLAsensio-CruzMICastro-AcostaACaleroCPozo-RodriguezFAUDIPOC and the European COPD Audit StudiesResults from an audit feedback strategy for chronic obstructive pulmonary disease in-hospital care: a joint analysis from the AUDIPOC and European COPD audit studiesPLoS One2014910e11039425333953
  • StephensonMMcArthurAGilesKLockwoodCAromatarisEPearsonAPrevention of falls in acute hospital settings: a multi-site audit and best practice implementation projectInt J Qual Health Care2016281929826678803
  • GottliebVLyngsoAMSaebyeDFrolichABackerVThe use of COPD maintenance therapy following spirometry in general practiceEur Clin Respir J Epub2016622
  • DietteGBDalalAAD’SouzaAOLunacsekOENagarSPTreatment patterns of chronic obstructive pulmonary disease in employed adults in the United StatesInt J Chron Obstruct Pulmon Dis20151041542225759574
  • BrusselleGPriceDGruffydd-JonesKThe inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UKInt J Chron Obstruct Pulmon Dis2015102207221726527869
  • PriceDWestDBrusselleGManagement of COPD in the UK primary-care setting: an analysis of real-life prescribing patternsInt J Chron Obstruct Pulmon Dis2014988990425210450
  • FalkJDikNBugdenSAn evaluation of early medication use for COPD: a population-based cohort studyInt J Chron Obstruct Pulmon Dis2016113101310827994449
  • Lizano-DiezIModamioPLopez-CalahorraPEvaluation of electronic prescription implementation in polymedicated users of Catalonia, Spain: a population-based longitudinal studyBMJ Open2014411e006177
  • MagnussenHWatzHKirstenAStepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationaleRespir Med2014108459359924477080